Lymphocyte proliferation inhibition

Lymphocyte proliferation inhibition" is not the name of a specific molecule or receptor but rather describes a biological process in which the division and expansion of lymphocytes are suppressed. This process can be induced by various agents—including drugs like glucocorticosteroids, small molecules such as serotonin, or gases like carbon monoxide—each acting through distinct molecular pathways. For example, glucocorticosteroids inhibit T cell proliferation via suppression of leukotriene B4 synthesis; carbon monoxide interferes with caspase activity required for T cell growth; serotonin reduces IL‑2 receptor expression on responder cells without affecting IL‑2 production itself. Because "lymphocyte proliferation inhibition" refers to an outcome or effect rather than an individual targetable entity (such as a protein or gene), it should not be considered a canonical therapeutic target but instead as an important immunological phenomenon relevant to drug action and disease pathogenesis[1][2][3].

Inhibition of arachidonic acid metabolism and leukotriene B4 production by glucocorticosteroids; Modulation of caspase activity by carbon monoxide and caspase inhibitors; Decreased IL‑2 receptor expression and altered cell activation by serotonin